Definium Therapeutics Inc (MNMD)

09:59 AM

Definium Therapeutics stock hits 52-week high at 19.78 USD - Investing.com

09:59 AM

Mar 31, 2026

New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States - BioSpace

Mar 31, 2026

Mar 31, 2026

Definium Therapeutics (DFTX) Study Highlights Rising GAD Rates i - GuruFocus

Mar 31, 2026

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds By Investing.com - Investing.com Australia

Mar 31, 2026

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds - Investing.com

Mar 31, 2026

Mar 31, 2026

Definium Therapeutics Inc (DFTX) Stock Price Quote Today & Current Price Chart - Capital.com

Mar 31, 2026

Mar 30, 2026

Definium Therapeutics Announces New Employee Inducement Grants - Yahoo! Finance Canada

Mar 30, 2026

Mar 29, 2026

A Look At Definium Therapeutics (DFTX) Valuation As Investor Day Highlights Late Stage DT120 ODT Pipeline - Sahm

Mar 29, 2026

Mar 29, 2026

Definium Therapeutics, Inc. (NASDAQ:DFTX) Short Interest Update - Defense World

Mar 29, 2026

Mar 28, 2026

symbol__ Stock Quote Price and Forecast - CNN

Mar 28, 2026

Mar 27, 2026

Definium Therapeutics Insider Sold Shares Worth $451,241, According to a Recent SEC Filing - marketscreener.com

Mar 27, 2026

Mar 27, 2026

Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 - BioSpace

Mar 27, 2026

Mar 26, 2026

Definium Therapeutics CMO Karlin sells $148k in shares By Investing.com - Investing.com Australia

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics CEO Barrow sells $451k in shares By Investing.com - Investing.com India

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics CEO Barrow sells $451k in shares - Investing.com

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics CMO Karlin sells $148k in shares - Investing.com

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics chief legal officer sells $197k in shares - Investing.com

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics chief legal officer sells $197k in shares By Investing.com - Investing.com UK

Mar 26, 2026

Mar 26, 2026

Definium (NASDAQ: DFTX) CMO sells shares to cover RSU tax - Stock Titan

Mar 26, 2026

Mar 26, 2026

Tax-cover sale by Definium (DFTX) legal chief totals 10,702 shares - Stock Titan

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics (DFTX) CEO share sale covers RSU tax withholding - Stock Titan

Mar 26, 2026

Mar 26, 2026

Definium Therapeutics brings Investor and Analyst Day event to New York - Traders Union

Mar 26, 2026

Mar 25, 2026

Robert Barrow files to sell 24,431 DFTX shares (DFTX) - Stock Titan

Mar 25, 2026

Mar 25, 2026

Affiliate sale notice for DFTX (NASDAQ: DFTX) — 8,018 shares reported - Stock Titan

Mar 25, 2026

Mar 25, 2026

Mark Sullivan to sell 10,702 shares (DFTX) under registered plan - Stock Titan

Mar 25, 2026

Mar 25, 2026

A Look At Definium Therapeutics (DFTX) Valuation After Its Recent Name Change And Share Price Momentum - Yahoo Finance

Mar 25, 2026

Mar 25, 2026

Definium Therapeutics Inc (DFTX) Says Cash Enough to Fund Operations into 2028 - Insider Monkey

Mar 25, 2026

Mar 24, 2026

9 Best Psychedelic Stocks to Buy in 2026 - Insider Monkey

Mar 24, 2026

Mar 23, 2026

Biotech Firm Developing LSD-Based Psychiatric Treatments Moves to Dismiss Trade Secrets Lawsuit, Calls Claims by Former Clinical Trial Vendor Legally Deficient - USA Herald

Mar 23, 2026

Mar 21, 2026

A Look At Definium Therapeutics (DFTX) Valuation After Strong Recent Share Price Momentum - Sahm

Mar 21, 2026

Mar 20, 2026

Definium Therapeutics (NASDAQ:DFTX) Sets New 12-Month HighHere's Why - MarketBeat

Mar 20, 2026

Mar 20, 2026

Definium Therapeutics stock hits 52-week high at 19.66 USD By Investing.com - Investing.com South Africa

Mar 20, 2026

Mar 20, 2026

Definium Therapeutics stock hits 52-week high at 19.66 USD - Investing.com

Mar 20, 2026

Mar 19, 2026

Definium Therapeutics Teases 3 Key DT-120 Data Readouts This Year, Highlights De-Risked Phase 3 Design - MarketBeat

Mar 19, 2026

Mar 18, 2026

Superstring Capital's Definium Therapeutics Investment: Q4 2025 PositionNews and Statistics - IndexBox

Mar 18, 2026

Mar 18, 2026

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names - AOL.com

Mar 18, 2026

Mar 18, 2026

DFTX: Definium Therapeutics, Inc.Detailed Earnings Estimates - Zacks Investment Research

Mar 18, 2026

Mar 17, 2026

DFTX: Pivotal phase III data for DT-120 in GAD and MDD expected this year, targeting broad market impact - TradingView

Mar 17, 2026

Mar 16, 2026

Definium Therapeutics, Inc. (NASDAQ:DFTX) Q4 2025 earnings call transcript - MSN

Mar 16, 2026

Mar 15, 2026

Definium Therapeutics stock hits 52-week high at 18.71 USD By Investing.com - Investing.com Nigeria

Mar 15, 2026

Mar 15, 2026

Boxer Capital Management LLC Takes Position in Definium Therapeutics, Inc. $DFTX - MarketBeat

Mar 15, 2026

Mar 15, 2026

Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference - MarketBeat

Mar 15, 2026

Mar 15, 2026

Commodore Capital LP Lowers Holdings in Definium Therapeutics, Inc. $DFTX - MarketBeat

Mar 15, 2026

Mar 15, 2026

Ally Bridge Group NY LLC Sells 364,728 Shares of Definium Therapeutics, Inc. $DFTX - MarketBeat

Mar 15, 2026

Mar 13, 2026

Rosalind Advisors Inc. Has $8.84 Million Holdings in Definium Therapeutics, Inc. $DFTX - MarketBeat

Mar 13, 2026